Cellctis 公司在大范围核酸酶基因工程研究领域处于地位，它的许多研究成果被成功运用于多种作物上，能对基因序列进行插入，删除或者改性操作，使得植物能表达出新的性状（比如抗旱，提高营养成分，抗病害等）目前有四个子公司Cellectis bioresearch, Cellectis therapeutics, Ectycell,Cellectis plant sciences服务于人类健康，生物产业，农业生物技术和干细胞领域，主要的工程技术是基因工程和蛋白工程技术。
- Worldwide pioneer in Genome engineering
- Established in 1999, listed on the NYSE-Euronext Alternext market in Paris since 2007
- Revenues 2010: € 15.8 M （70% sales from abroad）
- Staff: 152 including 60 PhDs
- 4 subsidiaries: Cellectis bioresearch, Cellectis therapeutics,Ectycell, Cellectis plant sciences
- Applications: human health, research and biomanufacturing, agrobiotechnology, stem cells
- Main technologies: Genome engineering, Protein engineering
- IP portfolio: 83 patents granted plus over 260 pending
- Location: Paris （France）, Evry （France）, Saint-Paul, Minnesota （USA）, Cambridge, Massachussets （USA）
